1. Home
  2. BBSI vs VTYX Comparison

BBSI vs VTYX Comparison

Compare BBSI & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

HOLD

Current Price

$36.68

Market Cap

887.4M

ML Signal

HOLD

Logo Ventyx Biosciences Inc.

VTYX

Ventyx Biosciences Inc.

HOLD

Current Price

$13.96

Market Cap

990.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBSI
VTYX
Founded
1965
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
887.4M
990.9M
IPO Year
1993
2021

Fundamental Metrics

Financial Performance
Metric
BBSI
VTYX
Price
$36.68
$13.96
Analyst Decision
Buy
Hold
Analyst Count
2
7
Target Price
$45.50
$13.50
AVG Volume (30 Days)
139.7K
6.0M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
0.87%
N/A
EPS Growth
10.03
N/A
EPS
2.08
N/A
Revenue
$1,223,992,000.00
N/A
Revenue This Year
$10.70
N/A
Revenue Next Year
$7.58
N/A
P/E Ratio
$17.60
N/A
Revenue Growth
9.64
N/A
52 Week Low
$33.01
$0.78
52 Week High
$49.65
$25.00

Technical Indicators

Market Signals
Indicator
BBSI
VTYX
Relative Strength Index (RSI) 43.06 75.17
Support Level $37.30 $13.94
Resistance Level $37.93 $14.07
Average True Range (ATR) 0.86 0.05
MACD -0.23 -0.07
Stochastic Oscillator 13.37 63.16

Price Performance

Historical Comparison
BBSI
VTYX

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Share on Social Networks: